Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-01-30 00:00:00 ET · period of report 2025-01-29 · accession 0001510281-25-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-01-30 | 2025-01-29 | HQL | Weinstein Boaz | 10% | S - Sale | $14.12 | -11.7K | 3.42M | -0.3% | -$164.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-29 | S | D | 11,674 | $14.12 | 3,418,349 | I - | — | — |